Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.

NCT02032095 is registered in ClinicalTrials.gov with Japan Blood Products Organization as lead sponsor.

NCT NCT02032095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02032095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
Lead sponsor
Japan Blood Products Organization
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2013
Completion date
September 30, 2015
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease